
Glyphic Biotechnologies selected as 1 of 25 Falling Walls Venture Winners
Glyphic Biotechnologies is 1 of 25 winners in the Falling Walls Venture 2021 competition and will be competing in Berlin for Science Startup Breakthrough of the Year.
Glyphic Biotechnologies is 1 of 25 winners in the Falling Walls Venture 2021 competition and will be competing in Berlin for Science Startup Breakthrough of the Year.
BioTools Innovator, a new program focused on accelerating life science tools and diagnostics, today announced the ten companies selected to participate in the organization’s inaugural three-month virtual mentorship-focused Accelerator program.
The whole human proteome may be free to browse thanks to DeepMind, but at the bleeding edge of biotech new proteins are made and tested every day, a complex and time-consuming process. Glyphic Biotechnologies accelerates the critical…
Glyphic Biotechnologies is a finalist in the Falling Walls Venture 2021 competition for Science Startup Breakthrough of the Year.
The protein sequencing space has a new entrant, as startup Glyphic Biotechnologies joins the raft of recently launched firms looking to tackle the proteomics and protein analysis market.
Glyphic Biotechnologies competed in the Sloan Healthcare Innovation Prize, a pitch competition for early-stage healthcare start-ups, and was selected as a top eight finalist. To learn more, visit MIT News.
Input your search keywords and press Enter.